NoticesDocument number 2026-20764New
Determination That LASIX (Furosemide) Oral Solution, 10 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that LASIX (furosemide) oral solution, 10 milligrams (mg)/ milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
From Federal Register — all agencies (federalregister.gov). First seen Oct 10, 2026.
Details
- Published
- Oct 9, 2026Find in source ↗
- Agency
- Health and Human Services Department; Food and Drug AdministrationFind in source ↗
- Action
- Notice.Find in source ↗
- Dockets
- Docket No. FDA-2026-P-4567Find in source ↗
- Citation
- 91 FR 64662Find in source ↗
- Official PDF
- govinfo.gov
History
No changes since RuleWatch first read this rule on Oct 10, 2026.
Sign in to keep notes on this rule, private or shared with your team.